|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Best Reviewer Awardees
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
All issues
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
Cancer Research and Treatment
Search
> Browse Articles > Search
Lung and Thoracic cancer
Selection Strategies and Practical Application of
BRAF
V600E-Mutated Non–Small Cell Lung Carcinoma
Inwoo Hwang, Yoon-La Choi, Hyunwoo Lee, Soohyun Hwang, Boram Lee, Hobin Yang, Chaithanya Chelakkot, Joungho Han
Cancer Res Treat.
2022;54(3):782-792. Published online November 23, 2021 DOI:
https://doi.org/10.4143/crt.2021.843
Web of Science 3
Crossref 3
Pediatric cancer
Effectiveness and Safety of Da
braf
enib in the Treatment of 20 Chinese Children with
BRAF
V600E
-Mutated Langerhans Cell Histiocytosis
Ying Yang, Dong Wang, Lei Cui, Hong-Hao Ma, Li Zhang, Hong-Yun Lian, Qing Zhang, Xiao-Xi Zhao, Li-Ping Zhang, Yun-Ze Zhao, Na Li, Tian-You Wang, Zhi-Gang Li, Rui Zhang
Cancer Res Treat.
2021;53(1):261-269. Published online September 15, 2020 DOI:
https://doi.org/10.4143/crt.2020.769
Web of Science 12
Crossref 17
Loss of LKB1 Protein Expression Correlates with Increased Risk of Recurrence and Death in Patients with Resected, Stage II or III Colon Cancer
Maria Sfakianaki, Chara Papadaki, Maria Tzardi, Maria Trypaki, Sardar Alam, Eleni D. Lagoudaki, Ippokratis Messaritakis, Odysseas Zoras, Dimitris Mavroudis, Vassilis Georgoulias, John Souglakos
Cancer Res Treat.
2019;51(4):1518-1526. Published online March 20, 2019 DOI:
https://doi.org/10.4143/crt.2019.008
Web of Science 7
Crossref 9
Active and Passive Smoking,
BRAF
V600E
Mutation Status, and the Risk of Papillary Thyroid Cancer: A Large-Scale Case-Control and Case-Only Study
Kyoung-Nam Kim, Yunji Hwang, Kyungsik Kim, Kyu Eun Lee, Young Joo Park, June Young Choi, Do Joon Park, BeLong Cho, Daehee Kang, Sue K. Park
Cancer Res Treat.
2019;51(4):1392-1399. Published online February 20, 2019 DOI:
https://doi.org/10.4143/crt.2018.612
Web of Science 5
Crossref 5
Genetic Alterations among Korean Melanoma Patients Showing Tumor Heterogeneity: A Comparison between Primary Tumors and Corresponding Metastatic Lesions
Si-Hyung Lee, Jee Eun Kim, Hong Sun Jang, Kyu Hyun Park, Byung Ho Oh, Sang Joon Shin, Kee Yang Chung, Mi Ryung Roh, Sun Young Rha
Cancer Res Treat.
2018;50(4):1378-1387. Published online January 22, 2018 DOI:
https://doi.org/10.4143/crt.2017.535
Web of Science 12
Crossref 10
Upregulation of MicroRNA-1246 Is Associated with
BRAF
Inhibitor Resistance in Melanoma Cells with Mutant
BRAF
Jae-Hyeon Kim, Jun-Ho Ahn, Michael Lee
Cancer Res Treat.
2017;49(4):947-959. Published online January 3, 2017 DOI:
https://doi.org/10.4143/crt.2016.280
Web of Science 36
Crossref 36
Genetic Alterations and Their Clinical Implications in High-Recurrence Risk Papillary Thyroid Cancer
Min-Young Lee, Bo Mi Ku, Hae Su Kim, Ji Yun Lee, Sung Hee Lim, Jong-Mu Sun, Se-Hoon Lee, Keunchil Park, Young Lyun Oh, Mineui Hong, Han-Sin Jeong, Young-Ik Son, Chung-Hwan Baek, Myung-Ju Ahn
Cancer Res Treat.
2017;49(4):906-914. Published online December 26, 2016 DOI:
https://doi.org/10.4143/crt.2016.424
Web of Science 18
Crossref 16
BRAF
-Activated Long Noncoding RNA Modulates Papillary Thyroid Carcinoma Cell Proliferation through Regulating Thyroid Stimulating Hormone Receptor
Haitao Zheng, Meng Wang, Lixin Jiang, Haidi Chu, Jinchen Hu, Jinyao Ning, Baoyuan Li, Dong Wang, Jie Xu
Cancer Res Treat.
2016;48(2):698-707. Published online August 12, 2015 DOI:
https://doi.org/10.4143/crt.2015.118
Web of Science 60
Crossref 52
Combination of Da
braf
enib and Trametinib in Patients with Metastatic
BRAF
V600E
-Mutated Thyroid Cancer
Youngkyung Jeon, Sehhoon Park, Se-Hoon Lee, Tae Hyuk Kim, Sun Wook Kim, Myung-Ju Ahn, Hyun Ae Jung, Jae Hoon Chung
Received December 4, 2023 Accepted March 3, 2024 Published online March 6, 2024
DOI:
https://doi.org/10.4143/crt.2023.1278
[Accepted]
1
Journal Impact Factor 4.6